Tumors resistant to radiation therapy may be controlled by the MET oncogene
Monday, April 4, 2011 - 16:31
in Health & Medicine
Ionizing radiation treats many cancers effectively, but in some patients a few tumor cells become resistant to radiation and go on to cause relapse and metastasis. A growth factor-receptor protein called MET may be a key player in these cells' resistance to radiation, and drugs targeting MET may help to prevent radiation-induced metastasis, according to a new study.